Due to the Memorial Day holiday (recognized on Monday, May 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the following plans for Domestic and International shipping:
In the first quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
Medical Laboratory Professionals Week is a time to appreciate the profound impact of laboratory medicine on healthcare and innovation.
Due to severe weather affecting the FedEx hub in Memphis, Tennessee, delays are anticipated. The Mayo Clinic Laboratories’ Global Logistics team will be diverting work to other commercial shipping options.
Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States. The test (test ID ASYNC) is available today for clients of Mayo Clinic Laboratories through the collaboration that combines the expertise of both organizations to enhance patient care and improve diagnostic accuracy for neurodegenerative diseases.
Mayo Clinic Laboratories is thrilled to participate in the American Academy of Neurology (AAN) Annual Meeting, which will be held in San Diego on April 5–9, 2025. Our lab and clinical experts are leading an evolution in neurology diagnostics and are committed to staying at the forefront of discovery.
Mayo Clinic Laboratories and KYAN Technologies announced a collaboration to validate and provide the KYAN test, Optim.AI™, across the United States.
In a Fierce Healthcare article, Dr. William Morice highlights AI, digital pathology, and mass spectrometry as key advancements revolutionizing healthcare diagnostics and treatment.
Due to weather affecting the FedEx hub in Memphis, TN, FedEx has initiated its contingency plan and expects delays. Mayo Clinic Laboratories’ Global Logistics team will proactivelymove work from FedEx to other commercial shipping options.
Mayo Clinic Laboratories is monitoring and tracking back-to-back winter storms moving through the Midwest and East Coast to minimize challenges. Engagement with our logistics partners is underway to minimize challenges. If any routes are modified or canceled, clients in the affected areas will be contacted directly.
Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares insights on balancing needs with future-oriented investments.
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients
The healthcare and diagnostics landscape is poised for transformative changes driven by technological advancements and evolving market dynamics.